Skip to Content

HHS Science Seminar for Media: Advances in Influenza Vaccine Technologies

(BUSINESS WIRE)--Dec 11, 2009 - The U.S. Department of Health and Human Services (HHS) will host a three-hour educational program for the media to learn more about ongoing government research efforts to develop and apply new technologies in the making of seasonal and pandemic influenza vaccines. The flu vaccines we use today are extraordinarily safe and have helped protect millions against influenza, but current egg-based technologies are outdated. There are increasing opportunities for new technologies to help better meet both seasonal influenza vaccine and pandemic preparedness and response needs. In these sessions, attendees will hear from and be able to question a number of HHS' top experts on current research efforts, advanced development support, and the regulatory science being applied to help transform vaccine technologies to support rapid, flexible and reliable approaches to influenza and other emerging threats.



  Francis Collins, M.D., Ph.D., Director, National Institutes of Health (NIH)


    Bruce Gellin, M.D., M.P.H., Director, National Vaccine Program Office, HHS


    Anthony Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, NIH


    Gary Nabel, M.D., Ph.D., Director, Vaccine Research Center, NIAID/NIH


    Carole Heilman, Ph.D., Director, Division of Microbiology and Infectious Diseases, NIAID/NIH


    Robin Robinson, Ph.D., Director, Biomedical Advanced Research & Development Authority/ HHS


    Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health, FDA (Acting)


    Other HHS officials TBD




  Science Seminar for Media: Advances in Influenza Vaccine Technologies


  Friday, December 11, 2009, 9:00 a.m. to 12:00 noon (EST)


  Wilson Hall, Building 1, National Institutes of Health, 9000 Rockville Pike, Bethesda, Md.


  HHS Press Office, (202) 690-6343 or



Credentialed media interested in attending this seminar should contact the HHS Press Office at 202-690-6343 or by email at for specific logistics information and pre-registration.

Attendees are encouraged to take Metrorail to the NIH campus, as visitor parking is limited. Metrorail users should take the Red Line and exit the system at the Medical Center station, which is located directly on the NIH campus.

The National Institutes of Health is a secure government facility with perimeter checkpoints and vehicle inspections.

If you plan to drive, plan extra time to get through the security checkpoints at the visitor entrances to campus. Be aware that visitor parking lots on the NIH campus can fill up quickly. Consider taking public transportation as an alternative. All visitor vehicles will be inspected before being allowed on campus. Visitors will be asked to show one (1) form of identification (a government-issued photo ID-driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure.

Visitors should continue to wear their identification prominently at all times while on campus.

Tune your radios to 1660 AM for further NIH traffic, parking and security advisories. For questions, please contact the NIH Office of Research Services (ORS) Information Line at or 301-594-6677, TTY 301-435-1908.

For additional NIH visitor information, please visit:



Contact: HHS Press Office
(202) 690-6343



Posted: December 2009